Advertisement
Drug company GlaxoSmithKline is out $3 billion after pleading guilty to promoting drugs for uses the FDA hasn't approved, the Justice Department said Monday
Have a story we missed? A link we have to click? A sharp opinion about the news? Instead of waiting for us to post it, tell us on the Open Wire.
Submit your news and ideas | See all reader postsThe Atlantic Wire is your authoritative guide to the news and ideas that matter most right now. Our team tracks newsmakers and opinions across the entire media spectrum: newspapers, web sites, television, radio and magazines.
But we do more than just collect information. By synthesizing, analyzing and summarizing what’s out there, and adding new information when we can, we are a news engine that gives you a quick and valuable account of the issues of the day.
Have a hot tip? A story we missed? Tell us on the Open Wire
How to send us editorial or technical feedback
Get Five Best Columns in your inbox each morning (preview)
